A Phase I Study for Evaluating the Safety and Tolerability of Zhishenjieyu Capsule
LIU Qi,LIU Yong-qiao,ZHANG Hong-yan,SHU Liang,LI Ling-zhi,HUANG Lan,MA Wen-bin,GAO Lian-sheng
DOI: https://doi.org/10.3321/j.issn:1003-3734.2009.09.014
2009-01-01
Abstract:Objective: To evaluate the safety and tolerability of Zhishenjieyu capsule in Chinese healthy volunteers.Methods: Thirty-eight healthy volunteers were recruited.Twenty-eight volunteers receiving single dose medication were randomly divided into 5 dosage groups;their oral doses were 729,927,1458,1944 and 2187mg,respectively.The other 10 were assigned to the multiple-dose group,and orally received 1944mg daily for 7 days.The safety profiles and tolerability were evaluated based on vital signs,routine blood and urine tests,hepatic and renal function examinations,blood electrolytes,electrocardiogram and incidence of adverse events.Results: Single doses did not affect the vital sign,hepatic or renal function of the subjects.High doses induced some adverse events,such as dry-mouth and hot feeling in palms.Multiple dose medication had more adverse events,including blush,increase or decrease of blood pressure,abnormal ECG,epistaxs,rash,dizziness and tachyrhythemia.All of the adverse events were mild,had no obvious effect on daily life,and disappeared after the medication without specific treatment.Conclusion: Zhishenjieyu capsule has good safety and tolerability in the dosage range by single or multiple medication.